GO:0034689 integrin alphaX-beta2 complex guide

The integrin alphaX-beta2 complex (GO:0034689) is a heterodimeric cell-surface adhesion receptor in which a single alphaX subunit pairs with a single beta2 subunit. In the Gene Ontology it is annotated as a cellular_component, reflecting its role as a discrete molecular machine at the plasma membrane rather than an enzymatic activity or a pathway. The complex is also referred to as the alphaX-beta2 integrin complex or the Itgax-Itgb2 complex, and it is widely recognized in immunology as complement receptor 4 (CR4). Because it mediates leukocyte adhesion, migration and phagocytosis, the complex is a central node in innate immune recognition and inflammatory signaling. For researchers, GO:0034689 matters because it provides a controlled vocabulary anchor for interpreting proteomic, transcriptomic and imaging data focused on myeloid cell surface receptors. Structural and biochemical work has shown that beta2 integrins form intracellular multi-protein complexes through their cytoplasmic domains, which couple ligand binding to cytoskeletal reorganization and signal transduction. This makes the alphaX-beta2 heterodimer a tractable model for studying how integrin ectodomains, transmembrane regions and cytoplasmic tails cooperate to produce cell-type-specific responses. Understanding the alphaX-beta2 complex also supports translational research. Alterations in beta2 integrin complex assembly or trafficking are associated with defects in leukocyte adhesion and with excessive inflammatory tissue damage. Consequently, the term is frequently used in functional enrichment analyses of immune cell datasets and in the design of CRISPR screens targeting integrin subunits and their intracellular partners.

GO:0034689 describes an integrin complex that comprises one alphaX subunit and one beta2 subunit. It is a cellular_component term, meaning it defines a stable supramolecular assembly rather than a process or a molecular function. The complex is a non-covalent heterodimer in which the alphaX and beta2 chains each contribute to a single ligand-binding headpiece and to paired transmembrane and cytoplasmic regions. Synonyms include alphaX-beta2 integrin complex and Itgax-Itgb2 complex.

The integrin alphaX-beta2 complex is important because it converts extracellular ligand engagement into intracellular cytoskeletal and signaling events in myeloid leukocytes. Beta2 integrins assemble intracellular multi-protein complexes through their cytoplasmic tails, and these assemblies determine how adhesion is coupled to cell activation, migration and phagocytosis. Because the alphaX-beta2 heterodimer is a defined cellular_component, it gives researchers a precise annotation target when interpreting immune cell proteomes and when designing perturbation experiments.

The following genes and proteins are directly relevant to the assembly, regulation and study of the integrin alphaX-beta2 complex (GO:0034689).

The integrin alphaX-beta2 complex is regulated through the availability of its alphaX and beta2 subunits and through the dynamic assembly of intracellular multi-protein complexes on the beta2 cytoplasmic tail. Structural analysis of beta2 integrin intracellular complexes indicates that the cytoplasmic region acts as a hub whose partner composition determines signaling output. Consequently, regulatory inputs that alter subunit expression, heterodimer trafficking or cytoplasmic partner recruitment will change the functional state of GO:0034689.

Defects in beta2 integrin complexes impair leukocyte adhesion and migration, which is the cellular basis of leukocyte adhesion deficiency. Because the alphaX-beta2 heterodimer depends on the beta2 subunit for assembly and intracellular partner recruitment, loss of beta2 function disrupts the entire complex. This makes GO:0034689 a useful annotation when interpreting patient variants that affect integrin heterodimer formation.

Excessive or poorly controlled leukocyte adhesion can contribute to inflammatory tissue damage. The alphaX-beta2 complex participates in myeloid cell adhesion and recognition, so changes in its assembly or partner recruitment may alter the intensity of inflammatory responses. Studying intracellular beta2 integrin complexes therefore helps explain how adhesion receptors shape inflammation.

Myeloid cells use adhesion receptors to enter tissues and to interact with other cells, processes that are relevant to tumor immunology and host defense. The alphaX-beta2 complex is part of this adhesion machinery, and its intracellular multi-protein complexes provide candidate nodes for functional interrogation. CRISPR perturbation of ITGAX and ITGB2 can be used to test how the complex contributes to myeloid cell behavior in these contexts.

Affinity purification coupled to mass spectrometry can identify proteins that assemble with the beta2 cytoplasmic tail, providing a direct readout of the intracellular multi-protein complexes associated with GO:0034689. This approach is most informative when paired with edited cell lines that express tagged or mutant beta2 subunits.

Fluorescence imaging of alphaX and beta2 subunits reveals where the heterodimer accumulates at the plasma membrane and how it redistributes during adhesion. Tagged knock-in lines allow the complex to be followed without overexpressing subunits.

Adhesion, spreading and phagocytosis assays measure the cellular consequences of alphaX-beta2 complex activity. Comparing wild-type and knockout cells provides causal evidence that the complex is required for a given phenotype.

RNA-seq datasets from myeloid cells can be analyzed for expression of ITGAX, ITGB2 and related adhesion genes, and GO:0034689 can be used as an enrichment anchor. This connects the cellular_component annotation to cell-state differences in immunity and inflammation.

Researchers studying integrin alphaX-beta2 complex-related genes often need to determine whether a candidate gene is causally involved in complex assembly, partner recruitment or downstream immune cell behavior. EDITGENE provides the CRISPR cell models and screening services needed to move from correlation to causal evidence for GO:0034689 biology.

GO:0034689, the integrin alphaX-beta2 complex, is a defined cellular_component that captures a heterodimeric adhesion receptor built from one alphaX and one beta2 subunit. Its biological importance lies in coupling extracellular recognition to intracellular multi-protein complex assembly, a mechanism that shapes myeloid leukocyte adhesion, migration and phagocytosis. Because the beta2 cytoplasmic tail is a central platform for these intracellular assemblies, the complex is a productive target for structural, proteomic and functional studies. CRISPR-based knockout, point-mutation, knock-in and overexpression models make it possible to test causal roles of ITGAX, ITGB2 and their partners in complex-dependent phenotypes. Combined with enrichment analysis and proteomic mapping, these approaches provide a rigorous framework for linking GO:0034689 to immune cell biology and disease.